Metraipolis › archive › dc_efcd7ae08c3c

Upadacitinib in Colonic Crohn's Disease: A Narrative Review of Mechanistic Rationale, Clinical Trial Evidence, and Real-World Outcomes — Europe PMC PMID:42903373

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42903373
DOI
10.34172/mejdd.3467
License (as archived)
solo-consultazione
Archived
2026-11-02T23:46:18.403Z
SHA-256 of the archived text
3528dfa76c4713cb2ce4ce5a43b62407138bbc6fd5db547500c3be605368dfa4
Stable URL of this page
https://metraipolis.com/documento/dc_efcd7ae08c3c

How to cite

Upadacitinib in Colonic Crohn's Disease: A Narrative Review of Mechanistic Rationale, Clinical Trial Evidence, and Real-World Outcomes — Europe PMC PMID:42903373 — Europe PMC (en), https://europepmc.org/article/MED/42903373 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_efcd7ae08c3c (Metraipolis archive dc_efcd7ae08c3c, sha256 3528dfa76c4713cb2ce4ce5a43b62407138bbc6fd5db547500c3be605368dfa4)
BibTeX
@misc{dcefcd7ae08c3c,
  title = {Upadacitinib in Colonic Crohn's Disease: A Narrative Review of Mechanistic Rationale, Clinical Trial Evidence, and Real-World Outcomes — Europe PMC PMID:42903373},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42903373},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_efcd7ae08c3c; sha256 3528dfa76c4713cb2ce4ce5a43b62407138bbc6fd5db547500c3be605368dfa4},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42903373. Agents can read the archived copy with the MCP tool read_document.